EIF4B AS A NOVEL TARGET IN EGFR EXPRESSING TRIPLE NEGATIVE BREAST CANCER

被引：0
|
作者：
Madden, J. M. [1 ]
Mueller, K. [1 ]
Bollig-Fischer, A. [1 ]
Stemmer, P. [1 ]
Boerner, J. [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu069.3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61P
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer
    Julie M. Madden
    Kelly L. Mueller
    Aliccia Bollig-Fischer
    Paul Stemmer
    Raymond R. Mattingly
    Julie L. Boerner
    Breast Cancer Research and Treatment, 2014, 147 : 283 - 293
  • [2] Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer
    Madden, Julie M.
    Mueller, Kelly L.
    Bollig-Fischer, Aliccia
    Stemmer, Paul
    Mattingly, Raymond R.
    Boerner, Julie L.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 283 - 293
  • [3] Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models
    Barbi, Joseph J.
    Smith, Randall
    Diba, Leila Zabihi
    Srinivasan, Aravind
    Ossevoort, Thomas
    Zollo, Robert
    He, Qian
    Venkatesh, Meera
    Arora, Aayush P.
    Washington, Deschana
    Yao, Song
    Walker, Sarah E.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [4] ERRβ: Validating a novel target for triple negative breast cancer
    Fernandez, Aileen I.
    Graham, Garrett
    Gyorffy, Balazs
    Cavalli, Luciane
    Riggins, Rebecca B.
    CANCER RESEARCH, 2017, 77
  • [5] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Tchou, Julia
    Wang, Liang-Chuan
    Selven, Ben
    Zhang, Hongtao
    Conejo-Garcia, Jose
    Borghaei, Hossein
    Kalos, Michael
    Vondeheide, Robert H.
    Albelda, Steven M.
    June, Carl H.
    Zhang, Paul J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 799 - 804
  • [6] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Julia Tchou
    Liang-Chuan Wang
    Ben Selven
    Hongtao Zhang
    Jose Conejo-Garcia
    Hossein Borghaei
    Michael Kalos
    Robert H. Vondeheide
    Steven M. Albelda
    Carl H. June
    Paul J. Zhang
    Breast Cancer Research and Treatment, 2012, 133 : 799 - 804
  • [7] eIF4B Is a Novel Target of CAMK2G and Promotes Proliferation of Malignant Cells in Myelofibrosis
    Sasaki, Ken
    Mizuno, Hideaki
    Ogawa, Tadayuki
    Masamoto, Yosuke
    Kurokawa, Mineo
    BLOOD, 2021, 138
  • [8] Targeting EGFR in Triple Negative Breast Cancer
    Ueno, Naoto T.
    Zhang, Dongwei
    JOURNAL OF CANCER, 2011, 2 : 324 - 328
  • [9] Synergistic activation of eIF4A by eIF4B and eIF4G
    Nielsen, Klaus H.
    Behrens, Manja A.
    He, Yangzi
    Oliveira, Cristiano L. P.
    Jensen, Lars Sottrup
    Hoffmann, Soren V.
    Pedersen, Jan S.
    Andersen, Gregers R.
    NUCLEIC ACIDS RESEARCH, 2011, 39 (07) : 2678 - 2689
  • [10] EGFR as a potent CAR T target in triple negative breast cancer brain metastases
    Subham, Siddharth
    Jeppson, John D.
    Worcester, Colette
    Schatmeyer, Bryan
    Zhao, Jie
    Madan, Rashna
    Lakis, Nelli S.
    Kimler, Bruce F.
    McGuirk, Joseph P.
    Chen, Ronald C.
    Stecklein, Shane R.
    Akhavan, David
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (01) : 57 - 69
12345